Cargando…

The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression

Senecavirus A (SVA)-associated porcine idiopathic vesicular disease (PIVD) and pseudorabies (PR) are highly contagious swine diseases that pose a significant threat to the swine industry in China. Since there is currently no effective commercial vaccine against SVA, the virus has spread widely throu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Qian, Zhu, Ling, Xu, Lei, Yang, Yanting, Zhang, Yang, Liu, Zheyan, Xu, Tong, Wen, Jianhua, Deng, Lishuang, Zhou, Yuancheng, Xu, Zhiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100989/
https://www.ncbi.nlm.nih.gov/pubmed/36976021
http://dx.doi.org/10.1128/spectrum.05229-22
_version_ 1785025409147994112
author Tao, Qian
Zhu, Ling
Xu, Lei
Yang, Yanting
Zhang, Yang
Liu, Zheyan
Xu, Tong
Wen, Jianhua
Deng, Lishuang
Zhou, Yuancheng
Xu, Zhiwen
author_facet Tao, Qian
Zhu, Ling
Xu, Lei
Yang, Yanting
Zhang, Yang
Liu, Zheyan
Xu, Tong
Wen, Jianhua
Deng, Lishuang
Zhou, Yuancheng
Xu, Zhiwen
author_sort Tao, Qian
collection PubMed
description Senecavirus A (SVA)-associated porcine idiopathic vesicular disease (PIVD) and pseudorabies (PR) are highly contagious swine diseases that pose a significant threat to the swine industry in China. Since there is currently no effective commercial vaccine against SVA, the virus has spread widely throughout China and its pathogenicity has increased over the last decade. In this study, a recombinant strain named rPRV-XJ-ΔTK/gE/gI-VP2 was constructed by using the pseudorabies virus (PRV) variant strain XJ as the parental virus and by deleting the TK/gE/gI gene while coexpressing SVA VP2. The recombinant strain can stably proliferate and express foreign protein VP2 in BHK-21 cells while having a similar virion appearance to that of the parental strain. rPRV-XJ-ΔTK/gE/gI-VP2 is safe and effective for BALB/c mice, inducing high levels of neutralizing antibodies against both PRV and SVA, providing 100% protection from the virulent PRV strain. Histopathological examination and quantitative PCR (qPCR) assay have demonstrated that SVA can infect mice through intranasal inoculation, while the vaccination of mice with rPRV-XJ-ΔTK/gE/gI-VP2 can significantly reduce SVA virus copies and alleviate the pathological inflammatory changes in the heart and liver. The evaluation of the safety and immunogenicity indicates that rPRV-XJ-ΔTK/gE/gI-VP2 holds promise as a candidate vaccine against PRV and SVA. IMPORTANCE This study reports the construction of a recombinant PRV with SVA for the first time, and the resulting virus, rPRV-XJ-ΔTK/gE/gI-VP2, can induce high levels of neutralizing antibodies against both PRV and SVA in model mice. These findings provide valuable insights for evaluating the effectiveness of rPRV-XJ-ΔTK/gE/gI-VP2 as a vaccine for pigs. Additionally, this study reports transient SVA infection in mice, with qPCR assays showing that the copies of the SVA 3D gene peaked at 3 to 6 days postinfection and fell below the sensitivity threshold by 14 days postinfection. The copies of the gene were more regular and at a higher level in the heart, liver, spleen, and lung tissue.
format Online
Article
Text
id pubmed-10100989
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-101009892023-04-14 The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression Tao, Qian Zhu, Ling Xu, Lei Yang, Yanting Zhang, Yang Liu, Zheyan Xu, Tong Wen, Jianhua Deng, Lishuang Zhou, Yuancheng Xu, Zhiwen Microbiol Spectr Research Article Senecavirus A (SVA)-associated porcine idiopathic vesicular disease (PIVD) and pseudorabies (PR) are highly contagious swine diseases that pose a significant threat to the swine industry in China. Since there is currently no effective commercial vaccine against SVA, the virus has spread widely throughout China and its pathogenicity has increased over the last decade. In this study, a recombinant strain named rPRV-XJ-ΔTK/gE/gI-VP2 was constructed by using the pseudorabies virus (PRV) variant strain XJ as the parental virus and by deleting the TK/gE/gI gene while coexpressing SVA VP2. The recombinant strain can stably proliferate and express foreign protein VP2 in BHK-21 cells while having a similar virion appearance to that of the parental strain. rPRV-XJ-ΔTK/gE/gI-VP2 is safe and effective for BALB/c mice, inducing high levels of neutralizing antibodies against both PRV and SVA, providing 100% protection from the virulent PRV strain. Histopathological examination and quantitative PCR (qPCR) assay have demonstrated that SVA can infect mice through intranasal inoculation, while the vaccination of mice with rPRV-XJ-ΔTK/gE/gI-VP2 can significantly reduce SVA virus copies and alleviate the pathological inflammatory changes in the heart and liver. The evaluation of the safety and immunogenicity indicates that rPRV-XJ-ΔTK/gE/gI-VP2 holds promise as a candidate vaccine against PRV and SVA. IMPORTANCE This study reports the construction of a recombinant PRV with SVA for the first time, and the resulting virus, rPRV-XJ-ΔTK/gE/gI-VP2, can induce high levels of neutralizing antibodies against both PRV and SVA in model mice. These findings provide valuable insights for evaluating the effectiveness of rPRV-XJ-ΔTK/gE/gI-VP2 as a vaccine for pigs. Additionally, this study reports transient SVA infection in mice, with qPCR assays showing that the copies of the SVA 3D gene peaked at 3 to 6 days postinfection and fell below the sensitivity threshold by 14 days postinfection. The copies of the gene were more regular and at a higher level in the heart, liver, spleen, and lung tissue. American Society for Microbiology 2023-03-28 /pmc/articles/PMC10100989/ /pubmed/36976021 http://dx.doi.org/10.1128/spectrum.05229-22 Text en Copyright © 2023 Tao et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Tao, Qian
Zhu, Ling
Xu, Lei
Yang, Yanting
Zhang, Yang
Liu, Zheyan
Xu, Tong
Wen, Jianhua
Deng, Lishuang
Zhou, Yuancheng
Xu, Zhiwen
The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression
title The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression
title_full The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression
title_fullStr The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression
title_full_unstemmed The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression
title_short The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression
title_sort construction and immunogenicity analyses of a recombinant pseudorabies virus with senecavirus a vp2 protein coexpression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100989/
https://www.ncbi.nlm.nih.gov/pubmed/36976021
http://dx.doi.org/10.1128/spectrum.05229-22
work_keys_str_mv AT taoqian theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT zhuling theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT xulei theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT yangyanting theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT zhangyang theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT liuzheyan theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT xutong theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT wenjianhua theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT denglishuang theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT zhouyuancheng theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT xuzhiwen theconstructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT taoqian constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT zhuling constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT xulei constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT yangyanting constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT zhangyang constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT liuzheyan constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT xutong constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT wenjianhua constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT denglishuang constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT zhouyuancheng constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression
AT xuzhiwen constructionandimmunogenicityanalysesofarecombinantpseudorabiesviruswithsenecavirusavp2proteincoexpression